Vulvar melanoma: a report of 20 cases and review of the literature - 24/08/11

Doi : 10.1016/j.jaad.2003.07.026

Mary Ellen Wechter, MD ^a, Stephen B Gruber, MD, PhD ^f, Hope K Haefner, MD ^a, Lori Lowe, MD ^b,^e, Jennifer L Schwartz, MD ^b, Kevin R Reynolds, MD ^a, Carolyn M Johnston, MD ^a, Timothy M Johnson, MD ^b,^c,^d,^⁎
^a Department of Obstetrics and Gynecology, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
^b Department of Derma- tology, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
^c Department of Otolaryngology, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
^d Department of Surgery, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
^e Department of Pathology, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA
^f Department of Internal Medicine and Epidemiology, University of Michigan Health System, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA

^*Reprints not available from authors. Correspondence to: Timothy M. Johnson, MD, University of Michigan Health System, 1910 Taubman Ctr, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0314, USA.

Abstract

Background

Vulvar melanoma is the second most common vulvar malignancy and represents a significant women's health issue.

Objective

To report experience with 21 cases of vulvar melanoma in 20 patients and to review the literature about the condition.

Methods

Parameters retrospectively reviewed included age at diagnosis, family history of melanoma, location on the vulva, atypical nevi, Breslow depth, ulceration status, histologic pattern, presenting signs and symptoms, and the results of sentinel lymph node biopsy. Molecular characterization of the melanocortin type 1 receptor was performed in 1 patient.

Results

A family history of cutaneous melanoma was present in 15% of cases. The mean Breslow depth was 2.8 mm (range, 0.0-11.0 mm). Ten patients successfully underwent sentinel lymph node biopsy, results of which were positive in 2 (20%). Reported for the first time is that one patient had a germline mutation in the melanocortin type 1 receptor.

Conclusion

Vulvar and cutaneous melanoma behave similarly despite their unique pathogeneses. Sentinel lymph node biopsy can be performed successfully for vulvar melanoma.

Le texte complet de cet article est disponible en PDF.

Plan

Funding source: Partially supported by grant UO1 CA83180 from the National Institutes of Health.
Conflict of interest: None identified.

Export

Vol 50 - N° 4

P. 554-562 - avril 2004 Retour au numéro

Article précédent

A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
Anne W Lucky, Daniel J Piacquadio, Cherie M Ditre, Frank Dunlap, Irwin Kantor, Amit G Pandya, Ronald C Savin, Michael D Tharp

| Article suivant

Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin
Jo-David Fine, Lorraine B Johnson, Madeline Weiner, Amy Stein, Chirayath Suchindran

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Vulvar melanoma: a report of 20 cases and review of the literature - 24/08/11

Abstract

Background

Objective

Methods

Results

Conclusion

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL